References
- Lode H, Allewelt M. Role of newer fluoroquinolones in lower respiratory tract infections. J Antimicrob Chemother 2002; 50: 151–4.
- Stahlmann R, Lode H. Toxicity of quinolones. Drugs 1999; 58: 37–42.
- Huston KA. Achillis tendinitis and tendon rupture due to fluoroquinolone antibiotics. New Engl J Med 1994; 331: 748.
- Zabraniecki L, Negrier I, Arnoud M, Bonnet C, Bertin P, Treves R. Fluoroquinolone induced tendinopathy: report of 6 cases. J Rheumatol 1996; 23: 516–20.
- Hooper CD. Expanding uses of fluoroquinolones: opportunities and challenges. Ann Intern Med 1998; 129: 908–10.
- Dalhoff A. In vitro activities of quinolones. Exp Opin Invest Drugs 1999; 8: 123–37.
- Lipsky BA, Baker CA. Fluoroquinolone toxicity profiles: a review focusing on newer agents. Clin Inf Dis 1999; 28: 352–64.
- Fleisch F, Hartmann K, Kuhn M. Fluoroquinolone-induced tendinopathy: also occurring with levofloxacin. Infection 2000; 28: 256–7.
- Jorgensen C, Anaya JM, Didry C, Canovas F, Serre I, Baldet P, et al. Arthropathy with Achilles tendon involvement induced by pefloxacin: case report. Rev Rhum Mal Osteoartic 1991; 58: 623–5.
- Shakibaei M, Pfister K, Schwabe R, Vormann J, Stahlmann R. Ultrastructure of Achilles tendons of rats treated with ofloxacin and fed a normal or magnesium-deficient diet. Antimicrob Agents Chemother 2000; 44: 261–6.
- Stahlmann R, Shakibaei M. Fluoroquinolon-induzierte tendopathien-klinische und experimentelle Aspekte. Chemother J 2000; 9: 140–7.
- Harrell RM. Fluoroquinolone-induced tendinopathy: what do we know? South Med J 1999; 92: 622–5